Gut microbiota and inflammatory factor characteristics in major depressive disorder patients with anorexia.
Anorexia
Gut microbiota
Inflammatory factors
Major depressive disorder
Journal
BMC psychiatry
ISSN: 1471-244X
Titre abrégé: BMC Psychiatry
Pays: England
ID NLM: 100968559
Informations de publication
Date de publication:
02 May 2024
02 May 2024
Historique:
received:
30
10
2023
accepted:
18
04
2024
medline:
3
5
2024
pubmed:
3
5
2024
entrez:
2
5
2024
Statut:
epublish
Résumé
This study aimed to explore the gut microbiota and inflammatory factor characteristics in major depressive disorder (MDD) patients with anorexia and to analyze the correlation between gut microbiota and inflammatory factors, anorexia, and HAMD scores. 46 MDD patients and 46 healthy controls (HC) were included in the study. The 46 MDD patients were divided into two groups according to whether they had anorexia:20 MDD without anorexia (MDA0 group) and 26 MDD with anorexia (MDA1 group). We used the Hamilton Depression Scale-24 (HAMD-24) to evaluate the depression status of all participants and 16 S ribosomal RNA (16 S rRNA)sequencing to evaluate the composition of the gut microbiota. Inflammatory factors in peripheral blood such as C-reactive protein (CRP) were detected using enzyme-linked immunosorbent assay (ELISA). Spearman's correlation analysis was used to evaluate the correlation between gut microbiota and inflammatory factors, HAMD scores, and anorexia. 1). CRP was significantly higher in the MDA0, MDA1, than HC. 2). An analysis of α-diversity shows: the Simpson and Pielou indices of the HC group are higher than the MDA1 group (P < 0.05). 3). The β-diversity analysis shows differences in the composition of microbial communities between the MDA0, MDA1, and HC group. 4). A correlation analysis showed that Blautia positively correlated with anorexia, HAMD scores, and CRP level, whereas Faecalibacterium, Bacteroides, Roseburia, and Parabacteroides negatively correlated with anorexia, HAMD scores, and CRP level. 5). The receiver operating characteristic (ROC) curve was drawn using the differential bacterial genera between MDD patients with or without anorexia as biomarkers to identify whether MDD patients were accompanied with anorexia, and its area under curve (AUC) was 0.85. The ROC curve was drawn using the differential bacterial genera between MDD patients with anorexia and healthy controls as biomarkers to diagnose MDD patients with anorexia, with its AUC was 0.97. This study suggested that MDD patients with anorexia had a distinct gut microbiota compared to healthy individuals, with higher level of CRP. Blautia was more abundant in MDD patients with anorexia and positively correlated with CRP, HAMD scores, and anorexia. The gut microbiota might have influenced MDD and anorexia through the inflammatory factor CRP.
Sections du résumé
BACKGROUND
BACKGROUND
This study aimed to explore the gut microbiota and inflammatory factor characteristics in major depressive disorder (MDD) patients with anorexia and to analyze the correlation between gut microbiota and inflammatory factors, anorexia, and HAMD scores.
METHODS
METHODS
46 MDD patients and 46 healthy controls (HC) were included in the study. The 46 MDD patients were divided into two groups according to whether they had anorexia:20 MDD without anorexia (MDA0 group) and 26 MDD with anorexia (MDA1 group). We used the Hamilton Depression Scale-24 (HAMD-24) to evaluate the depression status of all participants and 16 S ribosomal RNA (16 S rRNA)sequencing to evaluate the composition of the gut microbiota. Inflammatory factors in peripheral blood such as C-reactive protein (CRP) were detected using enzyme-linked immunosorbent assay (ELISA). Spearman's correlation analysis was used to evaluate the correlation between gut microbiota and inflammatory factors, HAMD scores, and anorexia.
RESULTS
RESULTS
1). CRP was significantly higher in the MDA0, MDA1, than HC. 2). An analysis of α-diversity shows: the Simpson and Pielou indices of the HC group are higher than the MDA1 group (P < 0.05). 3). The β-diversity analysis shows differences in the composition of microbial communities between the MDA0, MDA1, and HC group. 4). A correlation analysis showed that Blautia positively correlated with anorexia, HAMD scores, and CRP level, whereas Faecalibacterium, Bacteroides, Roseburia, and Parabacteroides negatively correlated with anorexia, HAMD scores, and CRP level. 5). The receiver operating characteristic (ROC) curve was drawn using the differential bacterial genera between MDD patients with or without anorexia as biomarkers to identify whether MDD patients were accompanied with anorexia, and its area under curve (AUC) was 0.85. The ROC curve was drawn using the differential bacterial genera between MDD patients with anorexia and healthy controls as biomarkers to diagnose MDD patients with anorexia, with its AUC was 0.97.
CONCLUSION
CONCLUSIONS
This study suggested that MDD patients with anorexia had a distinct gut microbiota compared to healthy individuals, with higher level of CRP. Blautia was more abundant in MDD patients with anorexia and positively correlated with CRP, HAMD scores, and anorexia. The gut microbiota might have influenced MDD and anorexia through the inflammatory factor CRP.
Identifiants
pubmed: 38698338
doi: 10.1186/s12888-024-05778-0
pii: 10.1186/s12888-024-05778-0
doi:
Substances chimiques
C-Reactive Protein
9007-41-4
RNA, Ribosomal, 16S
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
334Subventions
Organisme : National Natural Science Foundation of China
ID : 82201691
Organisme : Shanxi Provincial Science and Technology Department
ID : 20210302124193
Informations de copyright
© 2024. The Author(s).
Références
Peng R, Wang Y, Huang Y, Liu Z, Xu X, Ma Y, Wang L, Zhang M, Yan Y, Wang B, et al. The association of depressive symptoms with disability among adults in China. J Affect Disord. 2022;296:189–97.
pubmed: 34607060
doi: 10.1016/j.jad.2021.09.030
Cai H, Jin Y, Liu S, Zhang Q, Zhang L, Cheung T, Balbuena L, Xiang YT. Prevalence of suicidal ideation and planning in patients with major depressive disorder: a meta-analysis of observation studies. J Affect Disord. 2021;293:148–58.
pubmed: 34192629
doi: 10.1016/j.jad.2021.05.115
Friedrich MJ. Depression is the leading cause of disability around the World. JAMA. 2017;317(15):1517.
pubmed: 28418491
Celie JE, Loeys T, Desmet M, Verhaeghe P. The Depression Conundrum and the advantages of uncertainty. Front Psychol. 2017;8:939.
pubmed: 28701965
pmcid: 5487454
doi: 10.3389/fpsyg.2017.00939
Udo T, Grilo CM. Psychiatric and medical correlates of DSM-5 eating disorders in a nationally representative sample of adults in the United States. Int J Eat Disord. 2019;52(1):42–50.
pubmed: 30756422
doi: 10.1002/eat.23004
Guinhut M, Melchior JC, Godart N, Hanachi M. Extremely severe anorexia nervosa: Hospital course of 354 adult patients in a clinical nutrition-eating disorders-unit. Clin Nutr. 2021;40(4):1954–65.
pubmed: 33023762
doi: 10.1016/j.clnu.2020.09.011
Keski-Rahkonen A, Mustelin L. Epidemiology of eating disorders in Europe: prevalence, incidence, comorbidity, course, consequences, and risk factors. Curr Opin Psychiatry. 2016;29(6):340–5.
pubmed: 27662598
doi: 10.1097/YCO.0000000000000278
Salvatore P, Baldessarini RJ, Khalsa HK, Tohen M. Prodromal features in first-psychotic episodes of major affective and schizoaffective disorders. J Affect Disord. 2021;295:1251–8.
pubmed: 34706439
doi: 10.1016/j.jad.2021.08.099
Simmons WK, Burrows K, Avery JA, Kerr KL, Taylor A, Bodurka J, Potter W, Teague TK, Drevets WC. Appetite changes reveal depression subgroups with distinct endocrine, metabolic, and immune states. Mol Psychiatry. 2020;25(7):1457–68.
pubmed: 29899546
doi: 10.1038/s41380-018-0093-6
Ulfvebrand S, Birgegård A, Norring C, Högdahl L, von Hausswolff-Juhlin Y. Psychiatric comorbidity in women and men with eating disorders results from a large clinical database. Psychiatry Res. 2015;230(2):294–9.
pubmed: 26416590
doi: 10.1016/j.psychres.2015.09.008
Riquin E, Raynal A, Mattar L, Lalanne C, Hirot F, Huas C, Duclos J, Berthoz S, group, Godart E. N: Is the Severity of the Clinical Expression of Anorexia Nervosa Influenced by an Anxiety, Depressive, or Obsessive-Compulsive Comorbidity Over a Lifetime? Front Psychiatry 2021, 12:658416.
Cassioli E, Rossi E, Martelli M, Arganini F, Giuranno G, Siviglia S, Tarchi L, Faldi M, Castellini G, Ricca V. Longitudinal coupling between eating disorder psychopathology and depression in patients with Anorexia Nervosa and Bulimia Nervosa treated with enhanced cognitive behavior therapy: a one-year Follow-Up study. Brain Sci 2023, 13(4).
Meule A, Kolar DR, Gartner T, Osen B, Rauh E, Naab S, Voderholzer U. Depressive symptoms and weight change in inpatients with anorexia nervosa: a cross-lagged panel model. J Psychosom Res. 2023;172:111391.
pubmed: 37285655
doi: 10.1016/j.jpsychores.2023.111391
Patil CR, Suryakant Gawli C, Bhatt S. Targeting inflammatory pathways for treatment of the major depressive disorder. Drug Discov Today. 2023;28(9):103697.
pubmed: 37422168
doi: 10.1016/j.drudis.2023.103697
Kasarello K, Cudnoch-Jedrzejewska A, Czarzasta K. Communication of gut microbiota and brain via immune and neuroendocrine signaling. Front Microbiol. 2023;14:1118529.
pubmed: 36760508
pmcid: 9907780
doi: 10.3389/fmicb.2023.1118529
Bai S, Xie J, Bai H, Tian T, Zou T, Chen JJ. Gut microbiota-derived inflammation-related serum metabolites as potential biomarkers for major depressive disorder. J Inflamm Res. 2021;14:3755–66.
pubmed: 34393496
pmcid: 8354734
doi: 10.2147/JIR.S324922
Liu Y, Wang H, Gui S, Zeng B, Pu J, Zheng P, Zeng L, Luo Y, Wu Y, Zhou C, et al. Proteomics analysis of the gut-brain axis in a gut microbiota-dysbiosis model of depression. Transl Psychiatry. 2021;11(1):568.
pubmed: 34744165
pmcid: 8572885
doi: 10.1038/s41398-021-01689-w
Liu L, Wang H, Zhang H, Chen X, Zhang Y, Wu J, Zhao L, Wang D, Pu J, Ji P, et al. Toward a deeper understanding of gut microbiome in Depression: the Promise of Clinical Applicability. Adv Sci (Weinh). 2022;9(35):e2203707.
pubmed: 36285702
doi: 10.1002/advs.202203707
Zhou M, Fan Y, Xu L, Yu Z, Wang S, Xu H, Zhang J, Zhang L, Liu W, Wu L, et al. Microbiome and tryptophan metabolomics analysis in adolescent depression: roles of the gut microbiota in the regulation of tryptophan-derived neurotransmitters and behaviors in human and mice. Microbiome. 2023;11(1):145.
pubmed: 37386523
pmcid: 10311725
doi: 10.1186/s40168-023-01589-9
Zhang Y, Zhang J, Wu J, Zhu Q, Chen C, Li Y. Implications of gut microbiota dysbiosis and fecal metabolite changes in psychologically stressed mice. Front Microbiol. 2023;14:1124454.
pubmed: 37213506
pmcid: 10196128
doi: 10.3389/fmicb.2023.1124454
Varesi A, Campagnoli LIM, Chirumbolo S, Candiano B, Carrara A, Ricevuti G, Esposito C, Pascale A. The brain-gut-microbiota interplay in depression: a key to design innovative therapeutic approaches. Pharmacol Res. 2023;192:106799.
pubmed: 37211239
doi: 10.1016/j.phrs.2023.106799
Radjabzadeh D, Bosch JA, Uitterlinden AG, Zwinderman AH, Ikram MA, van Meurs JBJ, Luik AI, Nieuwdorp M, Lok A, van Duijn CM, et al. Gut microbiome-wide association study of depressive symptoms. Nat Commun. 2022;13(1):7128.
pubmed: 36473852
pmcid: 9726982
doi: 10.1038/s41467-022-34502-3
Tan Y, Zhou L, Huang J, Chen X, Wu Y, Song X, Wang J, Hu H, Yang Q. Vitamin B12, Folate, Homocysteine, Inflammatory mediators (Interleukin-6, Tumor Necrosis factor-alpha and C-Reactive protein) levels in adolescents with anxiety or depressive symptoms. Neuropsychiatr Dis Treat. 2023;19:785–800.
pubmed: 37056916
pmcid: 10089149
doi: 10.2147/NDT.S399378
Chamberlain SR, Cavanagh J, de Boer P, Mondelli V, Jones DNC, Drevets WC, Cowen PJ, Harrison NA, Pointon L, Pariante CM, et al. Treatment-resistant depression and peripheral C-reactive protein. Br J Psychiatry. 2019;214(1):11–9.
pubmed: 29764522
pmcid: 6124647
doi: 10.1192/bjp.2018.66
Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16(1):22–34.
pubmed: 26711676
pmcid: 5542678
doi: 10.1038/nri.2015.5
Paulsen O, Laird B, Aass N, Lea T, Fayers P, Kaasa S, Klepstad P. The relationship between pro-inflammatory cytokines and pain, appetite and fatigue in patients with advanced cancer. PLoS ONE. 2017;12(5):e0177620.
pubmed: 28542626
pmcid: 5444654
doi: 10.1371/journal.pone.0177620
Goodrose-Flores C, Bonn S, Klasson C, Helde Frankling M, Trolle Lagerros Y, Bjorkhem-Bergman L. Appetite in Palliative Cancer patients and its association with albumin, CRP and quality of life in men and women-cross-sectional data from the Palliative D-Study. Life (Basel) 2022, 12(5).
Karlovic D, Serretti A, Vrkic N, Martinac M, Marcinko D. Serum concentrations of CRP, IL-6, TNF-alpha and cortisol in major depressive disorder with melancholic or atypical features. Psychiatry Res. 2012;198(1):74–80.
pubmed: 22386567
doi: 10.1016/j.psychres.2011.12.007
Dunjic-Kostic B, Ivkovic M, Radonjic NV, Petronijevic ND, Pantovic M, Damjanovic A, Poznanovic ST, Jovanovic A, Nikolic T, Jasovic-Gasic M. Melancholic and atypical major depression–connection between cytokines, psychopathology and treatment. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:1–6.
pubmed: 23200828
doi: 10.1016/j.pnpbp.2012.11.009
Liu P, Gao M, Liu Z, Zhang Y, Tu H, Lei L, Wu P, Zhang A, Yang C, Li G, et al. Gut Microbiome Composition linked to inflammatory factors and cognitive functions in First-Episode, drug-naive major depressive disorder patients. Front Neurosci. 2021;15:800764.
pubmed: 35153660
doi: 10.3389/fnins.2021.800764
Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain Behav Immun. 2015;48:186–94.
pubmed: 25882912
doi: 10.1016/j.bbi.2015.03.016
Naseribafrouei A, Hestad K, Avershina E, Sekelja M, Linlokken A, Wilson R, Rudi K. Correlation between the human fecal microbiota and depression. Neurogastroenterol Motil. 2014;26(8):1155–62.
pubmed: 24888394
doi: 10.1111/nmo.12378
Kelly JR, Borre Y, C OB, Patterson E, El Aidy S, Deane J, Kennedy PJ, Beers S, Scott K, Moloney G, et al. Transferring the blues: Depression-associated gut microbiota induces neurobehavioural changes in the rat. J Psychiatr Res. 2016;82:109–18.
pubmed: 27491067
doi: 10.1016/j.jpsychires.2016.07.019
Breton J, Tirelle P, Hasanat S, Pernot A, L’Huillier C, do Rego JC, Dechelotte P, Coeffier M, Bindels LB, Ribet D. Gut microbiota alteration in a mouse model of Anorexia Nervosa. Clin Nutr. 2021;40(1):181–9.
pubmed: 32460959
doi: 10.1016/j.clnu.2020.05.002
Cox NJ, Bowyer RCE, Ni Lochlainn M, Wells PM, Roberts HC, Steves CJ. The composition of the gut microbiome differs among community dwelling older people with good and poor appetite. J Cachexia Sarcopenia Muscle. 2021;12(2):368–77.
pubmed: 33580637
pmcid: 8061352
doi: 10.1002/jcsm.12683
Jia W, Peng J, Zhang Y, Zhu J, Qiang X, Zhang R, Shi L. Amelioration impact of gut-brain communication on obesity control by regulating gut microbiota composition through the ingestion of animal-plant-derived peptides and dietary fiber: can food reward effect as a hidden regulator? Crit Rev Food Sci Nutr 2023:1–15.
Han H, Yi B, Zhong R, Wang M, Zhang S, Ma J, Yin Y, Yin J, Chen L, Zhang H. From gut microbiota to host appetite: gut microbiota-derived metabolites as key regulators. Microbiome. 2021;9(1):162.
pubmed: 34284827
pmcid: 8293578
doi: 10.1186/s40168-021-01093-y
Fujio-Vejar S, Vasquez Y, Morales P, Magne F, Vera-Wolf P, Ugalde JA, Navarrete P, Gotteland M. The gut microbiota of healthy Chilean subjects reveals a high abundance of the Phylum Verrucomicrobia. Front Microbiol. 2017;8:1221.
pubmed: 28713349
pmcid: 5491548
doi: 10.3389/fmicb.2017.01221
Li M, Su J, Wu J, Zhao D, Huang M, Lu Y, Zheng J, Li H. The Prebiotic Activity of a Novel Polysaccharide Extracted from Huangshui by Fecal Fermentation In Vitro. Foods 2023, 12(24).
Wei C, Yao L, Zhang L, Zhang Y, Luo Q, Qiu S, Zeng X, Chen S, Ye X. In Vitro Digestion and Fecal Fermentation of Peach Gum Polysaccharides with Different Molecular Weights and Their Impacts on Gut Microbiota. Foods 2022, 11(24).
Mirzaei R, Bouzari B, Hosseini-Fard SR, Mazaheri M, Ahmadyousefi Y, Abdi M, Jalalifar S, Karimitabar Z, Teimoori A, Keyvani H, et al. Role of microbiota-derived short-chain fatty acids in nervous system disorders. Biomed Pharmacother. 2021;139:111661.
pubmed: 34243604
doi: 10.1016/j.biopha.2021.111661
Silva YP, Bernardi A, Frozza RL. The role of short-chain fatty acids from gut microbiota in Gut-Brain communication. Front Endocrinol (Lausanne). 2020;11:25.
doi: 10.3389/fendo.2020.00025
You H, Tan Y, Yu D, Qiu S, Bai Y, He J, Cao H, Che Q, Guo J, Su Z. The therapeutic effect of SCFA-Mediated regulation of the intestinal environment on obesity. Front Nutr. 2022;9:886902.
pubmed: 35662937
pmcid: 9157426
doi: 10.3389/fnut.2022.886902
Joo MK, Ma X, Yoo JW, Shin YJ, Kim HJ, Kim DH. Patient-derived Enterococcus mundtii and its capsular polysaccharides cause depression through the downregulation of NF-kappaB-involved serotonin and BDNF expression. Microbes Infect. 2023;25(6):105116.
pubmed: 36758891
doi: 10.1016/j.micinf.2023.105116
Li J, Wang J, Wang M, Zheng L, Cen Q, Wang F, Zhu L, Pang R, Zhang A. Bifidobacterium: a probiotic for the prevention and treatment of depression. Front Microbiol. 2023;14:1174800.
pubmed: 37234527
pmcid: 10205982
doi: 10.3389/fmicb.2023.1174800
Liu X, Mao B, Gu J, Wu J, Cui S, Wang G, Zhao J, Zhang H, Chen W. Blautia-a new functional genus with potential probiotic properties? Gut Microbes. 2021;13(1):1–21.
pubmed: 34132169
doi: 10.1080/19490976.2021.1875796
Choy CT, Chan UK, Siu PLK, Zhou J, Wong CH, Lee YW, Chan HW, Tsui JCC, Loo SKF, Tsui SKW. A Novel E3 Probiotics Formula Restored Gut Dysbiosis and Remodelled Gut Microbial Network and Microbiome Dysbiosis Index (MDI) in Southern Chinese Adult Psoriasis Patients. Int J Mol Sci 2023, 24(7).
Nishino K, Nishida A, Inoue R, Kawada Y, Ohno M, Sakai S, Inatomi O, Bamba S, Sugimoto M, Kawahara M, et al. Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease. J Gastroenterol. 2018;53(1):95–106.
pubmed: 28852861
doi: 10.1007/s00535-017-1384-4
Chung YE, Chen HC, Chou HL, Chen IM, Lee MS, Chuang LC, Liu YW, Lu ML, Chen CH, Wu CS, et al. Exploration of microbiota targets for major depressive disorder and mood related traits. J Psychiatr Res. 2019;111:74–82.
pubmed: 30685565
doi: 10.1016/j.jpsychires.2019.01.016
Young SL, Simon MA, Baird MA, Tannock GW, Bibiloni R, Spencely K, Lane JM, Fitzharris P, Crane J, Town I, et al. Bifidobacterial species differentially affect expression of cell surface markers and cytokines of dendritic cells harvested from cord blood. Clin Diagn Lab Immunol. 2004;11(4):686–90.
pubmed: 15242942
pmcid: 440611
Zhang Y, Zhang R, Liu P, Wang J, Gao M, Zhang J, Yang J, Yang C, Zhang Y, Sun N. Characteristics and mediating Effect of Gut Microbiota with experience of Childhood Maltreatment in Major Depressive Disorder. Front Neurosci. 2022;16:926450.
pubmed: 35774560
pmcid: 9238290
doi: 10.3389/fnins.2022.926450
Tang Q, Shen D, Dai P, Liu J, Zhang M, Deng K, Li C. Pectin alleviates the pulmonary inflammatory response induced by PM(2.5) from a pig house by modulating intestinal microbiota. Ecotoxicol Environ Saf. 2023;261:115099.
pubmed: 37285678
doi: 10.1016/j.ecoenv.2023.115099
Moon J, Lee AR, Kim H, Jhun J, Lee SY, Choi JW, Jeong Y, Park MS, Ji GE, Cho ML, et al. Faecalibacterium prausnitzii alleviates inflammatory arthritis and regulates IL-17 production, short chain fatty acids, and the intestinal microbial flora in experimental mouse model for rheumatoid arthritis. Arthritis Res Ther. 2023;25(1):130.
pubmed: 37496081
pmcid: 10373287
doi: 10.1186/s13075-023-03118-3
Han X, Song Y, Huang R, Zhu M, Li M, Requena T, Wang H. Anti-inflammatory and gut microbiota modulation potentials of flavonoids extracted from Passiflora foetida Fruits. Foods 2023, 12(15).
Liu S, Yu H, Li P, Wang C, Liu G, Zhang X, Zhang C, Qi M, Ji H. Dietary nano-selenium alleviated intestinal damage of juvenile grass carp (Ctenopharyngodon idella) induced by high-fat diet: insight from intestinal morphology, tight junction, inflammation, anti-oxidization and intestinal microbiota. Anim Nutr. 2022;8(1):235–48.
pubmed: 34988305
doi: 10.1016/j.aninu.2021.07.001
Han W, Zheng Y, Wang L, An C. Disordered gut microbiota and changes in short-chain fatty acids and inflammatory processes in stress-vulnerable mice. J Neuroimmunol. 2023;383:578172.
pubmed: 37659269
doi: 10.1016/j.jneuroim.2023.578172
Sambataro D, Politi MR, Messina A, Scarpello L, Messina S, Guggino R, Carnaghi C, Caccialanza R, Gebbia V. Relationship of inflammatory parameters and nutritional status in Cancer patients. Anticancer Res. 2023;43(6):2821–9.
pubmed: 37247899
doi: 10.21873/anticanres.16451
van Norren K, Dwarkasing JT, Witkamp RF. The role of hypothalamic inflammation, the hypothalamic-pituitary-adrenal axis and serotonin in the cancer anorexia-cachexia syndrome. Curr Opin Clin Nutr Metab Care. 2017;20(5):396–401.
pubmed: 28708669
doi: 10.1097/MCO.0000000000000401
Wong DH, Beiko RG. Transfer of energy pathway genes in microbial enhanced biological phosphorus removal communities. BMC Genomics. 2015;16(1):526.
pubmed: 26173980
pmcid: 4502571
doi: 10.1186/s12864-015-1752-5
Zhang Y, Li X, Huang G, Wang H, Chen H, Su Y, Yu K, Zhu W. Propionate stimulates the secretion of satiety hormones and reduces acute appetite in a cecal fistula pig model. Anim Nutr. 2022;10:390–8.
pubmed: 35949198
pmcid: 9356018
doi: 10.1016/j.aninu.2022.06.003
Chen K, Hu M, Tang M, Gao C, Wang H, Man S, Lu F. Oligosaccharide and short-chain fatty acid: a double-edged sword in obese mice by regulating food intake and fat synthesis. Food Res Int. 2022;159:111619.
pubmed: 35940810
doi: 10.1016/j.foodres.2022.111619
Sencio V, Benech N, Robil C, Deruyter L, Heumel S, Machelart A, Sulpice T, Lamaziere A, Grangette C, Briand F, et al. Alteration of the gut microbiota’s composition and metabolic output correlates with COVID-19-like severity in obese NASH hamsters. Gut Microbes. 2022;14(1):2100200.
pubmed: 35830432
pmcid: 9291689
doi: 10.1080/19490976.2022.2100200
Maunder K, Molloy E, Jenkins E, Hayden J, Adamis D, McNicholas F. Anorexia nervosa in vivo cytokine production: a systematic review. Psychoneuroendocrinology. 2023;158:106390.
pubmed: 37769539
doi: 10.1016/j.psyneuen.2023.106390
Jennings JH, Rizzi G, Stamatakis AM, Ung RL, Stuber GD. The inhibitory circuit architecture of the lateral hypothalamus orchestrates feeding. Science. 2013;341(6153):1517–21.
pubmed: 24072922
pmcid: 4131546
doi: 10.1126/science.1241812
Lebow MA, Chen A. Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders. Mol Psychiatry. 2016;21(4):450–63.
pubmed: 26878891
pmcid: 4804181
doi: 10.1038/mp.2016.1
Wang Y, Kim J, Schmit MB, Cho TS, Fang C, Cai H. A bed nucleus of stria terminalis microcircuit regulating inflammation-associated modulation of feeding. Nat Commun. 2019;10(1):2769.
pubmed: 31235690
pmcid: 6591327
doi: 10.1038/s41467-019-10715-x
Piątkowska-Chmiel I, Krawiec P, Ziętara KJ, Pawłowski P, Samardakiewicz M, Pac-Kożuchowska E, Herbet M. The impact of chronic stress related to COVID-19 on eating behaviors and the risk of obesity in children and adolescents. Nutrients 2023, 16(1).
Siff T, Parajuli P, Razzaque MS, Atfi A. Cancer-mediated muscle Cachexia: etiology and clinical management. Trends Endocrinol Metab. 2021;32(6):382–402.
pubmed: 33888422
pmcid: 8102392
doi: 10.1016/j.tem.2021.03.007
Ispoglou T, McCullough D, Windle A, Nair S, Cox N, White H, Burke D, Kanatas A, Prokopidis K. Addressing cancer anorexia-cachexia in older patients: potential therapeutic strategies and molecular pathways. Clin Nutr. 2024;43(2):552–66.
pubmed: 38237369
doi: 10.1016/j.clnu.2024.01.009
Pastis I, Santos MG, Paruchuri A. Exploring the role of inflammation in major depressive disorder: beyond the monoamine hypothesis. Front Behav Neurosci. 2023;17:1282242.
pubmed: 38299049
doi: 10.3389/fnbeh.2023.1282242
Tan Y, Xu M, Lin D. Review of research progress on intestinal microbiota based on metabolism and inflammation for depression. Arch Microbiol. 2024;206(4):146.
pubmed: 38462572
doi: 10.1007/s00203-024-03866-z
Beurel E, Toups M, Nemeroff CB. The bidirectional relationship of depression and inflammation: double trouble. Neuron. 2020;107(2):234–56.
pubmed: 32553197
pmcid: 7381373
doi: 10.1016/j.neuron.2020.06.002
Bhatt S, Devadoss T, Jha NK, Baidya M, Gupta G, Chellappan DK, Singh SK, Dua K. Targeting inflammation: a potential approach for the treatment of depression. Metab Brain Dis. 2023;38(1):45–59.
pubmed: 36239867
doi: 10.1007/s11011-022-01095-1
Teixeira SA, Moreira JLS, Sousa NRT, Pereira AMC, Rodrigues PN, Santos ASD, Andrade A, Rolim Neto ML, Araújo JEB, Machado SSF, et al. Molecular basis and clinical perspectives of deep brain stimulation for major depressive disorder. J Cereb Blood Flow Metab. 2022;42(4):683–5.
pubmed: 35048722
pmcid: 9051149
doi: 10.1177/0271678X221074279
Jiao H, Fan Y, Gong A, Li T, Fu X, Yan Z. Xiaoyaosan ameliorates CUMS-induced depressive-like and anorexia behaviors in mice via necroptosis related cellular senescence in hypothalamus. J Ethnopharmacol. 2024;318(Pt A):116938.
pubmed: 37495029
doi: 10.1016/j.jep.2023.116938
Colella M, Charitos IA, Ballini A, Cafiero C, Topi S, Palmirotta R, Santacroce L. Microbiota revolution: how gut microbes regulate our lives. World J Gastroenterol. 2023;29(28):4368–83.
pubmed: 37576701
pmcid: 10415973
doi: 10.3748/wjg.v29.i28.4368